Literature DB >> 19308312

FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis.

Jing-Houng Wang1, Chi-Sin Changchien, Chao-Hung Hung, Hock-Liew Eng, Wei-Chih Tung, Kwong-Ming Kee, Chien-Hung Chen, Tsung-Hui Hu, Chuan-Mo Lee, Sheng-Nan Lu.   

Abstract

BACKGROUND: The aim of this study was to assess the diagnostic performances of liver stiffness measurement (LSM), ultrasonography (US) and their combined use in predicting the extent of hepatic fibrosis.
METHODS: Consecutive patients with chronic hepatitis B (HBV) or hepatitis C virus (HCV) infections, with indications for liver biopsy, were prospectively enrolled. LSM was performed on the same day as biopsy. US scores, including assessment of liver surface, liver parenchyma, intrahepatic vessels and spleen index, were used to assess the degree of hepatic fibrosis. The pathological findings were used as a reference standard and diagnostic accuracy was assessed and compared.
RESULTS: Three-hundred and twenty patients, including 199 men and 121 women, with a mean age of 50.8 years, were analyzed. There were 214 (66.9%) HCV patients, 88 (27.5%) HBV patients and 18 (5.6%) patients with both HCV and HBV. LSM correlated significantly with the hepatic fibrosis (F) scores, necro-inflammatory activity and US scores in multivariate analysis. The diagnostic accuracy of LSM is significantly superior to US, and equal to combined LSM with US, in the prediction of all HCV-related fibrosis scores. The cut-off value of LSM is 6 kPa for diagnosing F > =1, with a positive predictive value of 91%. Also, the cut-off value is 12 kPa for the prediction of cirrhosis, with a negative predictive value of 94%.
CONCLUSIONS: LSM is useful for predicting hepatic fibrosis and excluding cirrhosis. A combination of LSM and US does not improve the accuracy in assessing hepatic fibrosis.

Entities:  

Mesh:

Year:  2009        PMID: 19308312     DOI: 10.1007/s00535-009-0017-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  15 in total

1.  Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

Authors:  Christophe Corpechot; Ahmed El Naggar; Armelle Poujol-Robert; Marianne Ziol; Dominique Wendum; Olivier Chazouillères; Victor de Lédinghen; Daniel Dhumeaux; Patrick Marcellin; Michel Beaugrand; Raoul Poupon
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

2.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.

Authors:  Mirella Fraquelli; Cristina Rigamonti; Giovanni Casazza; Dario Conte; Maria Francesca Donato; Guido Ronchi; Massimo Colombo
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

5.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

6.  Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

Authors:  Nathalie Ganne-Carrié; Marianne Ziol; Victor de Ledinghen; Catherine Douvin; Patrick Marcellin; Laurent Castera; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

7.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

8.  Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis.

Authors:  Chao-Hung Hung; Sheng-Nan Lu; Jing-Houng Wang; Chuan-Mo Lee; Tsung-Ming Chen; Hung-Da Tung; Chien-Hung Chen; Wu-Shiung Huang; Chi-Sin Changchien
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

9.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

10.  Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.

Authors:  E Gómez-Dominguez; J Mendoza; L García-Buey; M Trapero; J P Gisbert; E A Jones; R Moreno-Otero
Journal:  Aliment Pharmacol Ther       Date:  2007-12-10       Impact factor: 8.171

View more
  44 in total

Review 1.  Accuracy of ultrasound to identify chronic liver disease.

Authors:  Richard Allan; Kerry Thoirs; Maureen Phillips
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

Review 2.  Liver elastography, comments on EFSUMB elastography guidelines 2013.

Authors:  Xin-Wu Cui; Mireen Friedrich-Rust; Chiara De Molo; Andre Ignee; Dagmar Schreiber-Dietrich; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

3.  Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis.

Authors:  Yuan-Hung Kuo; Sheng-Nan Lu; Chao-Hung Hung; Kwong-Ming Kee; Chien-Hung Chen; Tsung-Hui Hu; Chuan-Mo Lee; Chi-Sin Changchien; Jing-Houng Wang
Journal:  Hepatol Int       Date:  2010-10-08       Impact factor: 6.047

4.  Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance.

Authors:  Dong Hyun Sinn; Jieun Yi; Moon Seok Choi; Dongil Choi; Geum-Youn Gwak; Yong-Han Paik; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Hepatol Int       Date:  2013-07-27       Impact factor: 6.047

5.  Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.

Authors:  Vincent Wai-Sun Wong; Pietro Lampertico; Victor de Lédinghen; Pik Eu Chang; Seung Up Kim; Yongpeng Chen; Henry Lik-Yuen Chan; Giampaolo Mangia; Juliette Foucher; Wan Cheng Chow; Sang Hoon Ahn; Jinlin Hou
Journal:  Dig Dis Sci       Date:  2015-01-07       Impact factor: 3.199

6.  Assessment of liver volume variation to evaluate liver function.

Authors:  Cong Tong; Xinsen Xu; Chang Liu; Tianzheng Zhang; Kai Qu
Journal:  Front Med       Date:  2012-09-28       Impact factor: 4.592

7.  Transient elastography improves detection of liver cirrhosis compared to routine screening tests.

Authors:  Thomas Göbel; Janine Schadewaldt-Tümmers; Lucas Greiner; Christopher Poremba; Dieter Häussinger; Andreas Erhardt
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

8.  Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

Authors:  Thierry Poynard; Yen Ngo; Mona Munteanu; Dominique Thabut; Vlad Ratziu
Journal:  Curr Hepat Rep       Date:  2011-03-01

Review 9.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

10.  Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?

Authors:  Behairy El-Sayed Behairy; Mostafa Mohamed Sira; Khaled Refat Zalata; El-Sayed Ebrahem Salama; Mohamed Ahmed Abd-Allah
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.